Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
This contract is for the provision of Transitional Drugs 4 - namely Ticagrelor and Eltrombopag
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Amarox Pharma | Procurement ID: PRNG-5488-RGMD | £137,717 | 1 lot Lot 1 | - |
| Novartis | Procurement ID: PJTX-5182-QVLR | £137,717 | 1 lot Lot 1 | - |
| Novumgen Ltd | 13510476 | £137,717 | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 11 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Oct 2025 – Jan 2027 | £4,090,814 £137,717 initial term | 11 | Amarox Pharma Novartis Novumgen Ltd | active |
Weightings from the notice.